Cellosaurus cell line OV-UL-2 (CVCL

Cross-references
Cell line name	OV-UL-2
Synonyms	OVarian-ULm-2
Accession	CVCL_X963
Resource Identification Initiative	To cite this cell line use: OV-UL-2 (RRID:CVCL_X963)
Sequence variations	Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr205Cys (c.614A>G); ClinVar=VCV000376681; Zygosity=Unspecified (PubMed=15153938).
Disease	Ovarian carcinoma (NCIt: C4908)
Species of origin	Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell	Female
Age at sampling	Age unspecified
Category	Cancer cell line
Publications	PubMed=11242531; DOI=10.1089/10430340150504019 Ansgar Bruning, Tanja Kohler, Sven Roy Quist, Shan Wang-Gohrke, Volker J. Mobus, Rolf Kreienberg, Ingo Bernard Runnebaum; Adenoviral transduction efficiency of ovarian cancer cells can be limited by loss of integrin beta3 subunit expression and increased by reconstitution of integrin alphaVbeta3. Hum. Gene Ther. 12:391-399(2001) PubMed=15153938; DOI=10.1038/sj.cgt.7700727 Sven Roy Quist, Shan Wang-Gohrke, Tanja Kohler, Rolf Kreienberg, Ingo Bernard Runnebaum; Cooperative effect of adenoviral p53 gene therapy and standard chemotherapy in ovarian cancer cells independent of the endogenous p53 status. Cancer Gene Ther. 11:547-554(2004)
Cell line databases/resources	cancercelllines; CVCL_X963
Encyclopedic resources	Wikidata; Q54936875
Entry history
Entry creation	05-Sep-2014
Last entry update	19-Dec-2024
Version number	10